ROGERS CORP (ROG) Q3 2025 10-Q Quarterly Report
Filed: Oct 30, 2025Period ending Sep 30, 2025
Health Care
Plastic Materials, Synth Resins & Nonvulcan ElastomersSEC EDGAR ROGERS CORP (ROG) 10-Q quarterly report for Q3 2025, filed with SEC EDGAR on Oct 30, 2025 for the fiscal period ending Sep 30, 2025. This page provides AI-powered analysis including management discussion & analysis (MD&A), risk factor updates, and key quarterly financial data such as revenue and net income extracted from XBRL.
ROGERS CORP Q3 2025 10-Q Analysis
Risk Factors
- • No material changes in risk factors from 2024 10-K reported in this 10-Q
- • Carried forward risk: global supply chain disruptions impacting production schedules
ROGERS CORP Q3 2025 Quarterly FinancialsXBRL
Revenue
$216M
▲ +2.7% YoY▲ +6.5% QoQ
Net Income
$9M
▼ -19.6% YoY▲ +111.7% QoQ
Gross Margin
33.5%
▼ -176bp YoY▲ +191bp QoQ
Operating Margin
7.3%
▲ +33bp YoY▲ +4055bp QoQ
Net Margin
4.0%
▼ -111bp YoY▲ +4027bp QoQ
ROE
0.7%
Total Assets
$1.4B
EPS (Diluted)
$0.45
▼ -22.4% YoY▲ +111.3% QoQ
Operating Cash Flow
$29M
▼ -31.8% YoY▲ +110.9% QoQ
Source: XBRL data from ROGERS CORP Q3 2025 10-Q filing on SEC EDGAR. All figures in USD.
Get deeper insights on ROGERS CORP
Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.